DE2359564C2 - β-Urogastron und γ-Urogastron, Verfahren zu deren Gewinnung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen - Google Patents

β-Urogastron und γ-Urogastron, Verfahren zu deren Gewinnung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen

Info

Publication number
DE2359564C2
DE2359564C2 DE2359564A DE2359564A DE2359564C2 DE 2359564 C2 DE2359564 C2 DE 2359564C2 DE 2359564 A DE2359564 A DE 2359564A DE 2359564 A DE2359564 A DE 2359564A DE 2359564 C2 DE2359564 C2 DE 2359564C2
Authority
DE
Germany
Prior art keywords
urogastron
column
urogastrone
acetic acid
fractions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2359564A
Other languages
German (de)
English (en)
Other versions
DE2359564A1 (de
Inventor
Harold Gregory
Ian Robert Macclesfield Cheshire Willshire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of DE2359564A1 publication Critical patent/DE2359564A1/de
Application granted granted Critical
Publication of DE2359564C2 publication Critical patent/DE2359564C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE2359564A 1972-11-29 1973-11-29 β-Urogastron und γ-Urogastron, Verfahren zu deren Gewinnung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen Expired DE2359564C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5508972A GB1394846A (en) 1972-11-29 1972-11-29 Polypeptides

Publications (2)

Publication Number Publication Date
DE2359564A1 DE2359564A1 (de) 1974-05-30
DE2359564C2 true DE2359564C2 (de) 1984-06-14

Family

ID=10472925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2359564A Expired DE2359564C2 (de) 1972-11-29 1973-11-29 β-Urogastron und γ-Urogastron, Verfahren zu deren Gewinnung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen

Country Status (13)

Country Link
US (1) US3883497A (enExample)
JP (1) JPS5930685B2 (enExample)
AU (1) AU477190B2 (enExample)
BE (1) BE807934A (enExample)
CH (1) CH608372A5 (enExample)
DE (1) DE2359564C2 (enExample)
FR (1) FR2207726B1 (enExample)
GB (1) GB1394846A (enExample)
HU (1) HU169712B (enExample)
IL (1) IL43499A (enExample)
NL (1) NL185345C (enExample)
SE (1) SE411297B (enExample)
ZA (1) ZA738179B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848051A1 (de) * 1977-11-08 1979-05-10 Genentech Inc Synthetische dna und verfahren zu ihrer herstellung
JPS58134029A (ja) * 1982-02-02 1983-08-10 Nippon Chem Res Kk 胃酸分泌抑制成分の分別採取法
US4764593A (en) * 1983-04-25 1988-08-16 Amgen Inc. Manufacture and expression of genes for urogastrone and polypeptide analogs thereof
GB8409961D0 (en) * 1984-04-17 1984-05-31 Searle & Co Pharmaceutical compositions
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
GB8509448D0 (en) * 1985-04-12 1985-05-15 Ici Plc Urogastrone
JPS6351583U (enExample) * 1986-09-22 1988-04-07
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5222978A (en) * 1987-08-26 1993-06-29 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5306289A (en) * 1987-08-26 1994-04-26 United States Surgical Corporation Braided suture of improved characteristics
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
US5366081A (en) * 1987-08-26 1994-11-22 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5226912A (en) * 1987-08-26 1993-07-13 United States Surgical Corporation Combined surgical needle-braided suture device
US5359831A (en) * 1989-08-01 1994-11-01 United States Surgical Corporation Molded suture retainer
US5219998A (en) * 1990-06-04 1993-06-15 Levin Robert H Yeast-derived epidermal growth factor
US5434135A (en) * 1990-08-02 1995-07-18 Indu Parikh Growth factor compositions, preparation and use
CA2059245C (en) * 1991-02-08 2004-07-06 Michael P. Chesterfield Method and apparatus for calendering and coating/filling sutures
US20090192554A1 (en) 2008-01-29 2009-07-30 Confluent Surgical, Inc. Bioabsorbable block copolymer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2292841A (en) * 1939-03-11 1942-08-11 Michael Reese Res Foundation Method of obtaining a therapeutic product for inhibiting gastric motility and secretion
US2357103A (en) * 1942-08-04 1944-08-29 Merck & Co Inc Preparation of pyrogen-free urogastrone

Also Published As

Publication number Publication date
NL7315504A (enExample) 1974-05-31
CH608372A5 (enExample) 1979-01-15
SE411297B (sv) 1979-12-17
FR2207726A1 (enExample) 1974-06-21
US3883497A (en) 1975-05-13
IL43499A0 (en) 1974-01-14
GB1394846A (en) 1975-05-21
FR2207726B1 (enExample) 1978-01-13
BE807934A (fr) 1974-05-28
NL185345B (nl) 1989-10-16
ZA738179B (en) 1974-09-25
AU6195173A (en) 1975-05-01
DE2359564A1 (de) 1974-05-30
JPS5930685B2 (ja) 1984-07-28
IL43499A (en) 1976-05-31
AU477190B2 (en) 1976-10-14
NL185345C (nl) 1990-03-16
JPS4993516A (enExample) 1974-09-05
HU169712B (enExample) 1977-02-28

Similar Documents

Publication Publication Date Title
DE2359564C2 (de) β-Urogastron und γ-Urogastron, Verfahren zu deren Gewinnung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen
DE69002385T2 (de) Isolierung und Strukturbestimmung des zytostatischen linearen Depsipeptids Dolastatin 15.
EP0167575B1 (de) Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
DE69109426T2 (de) Extrakt aus Ginkgo biloba-Blättern, insbesondere für intravenöse Injektionen oder Infusionen, ein Verfahren zur Herstellung des Extraktes und Ampullenzubereitungen, die diesen Extrakt enthalten.
DE69832158T2 (de) Isolierung und strukturelle aufklärung der kryostatischen linearen und cyclo-depsipeptide dolastatin 16, dolastatin 17, und dolastatin 18
DE3587603T2 (de) Aus follikularer eierstockflüssigkeit isoliertes inhibin.
DE3881801T2 (de) Menschliche somatomedin-träger-protein-untereinheiten und verfahren zu ihrer herstellung.
DE3650088T2 (de) Inhibin und dessen reinigung.
DE2415101A1 (de) Pharmazeutische zusammensetzungen
DE2500076C3 (de) Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
DE3878231T2 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
DE69228749T2 (de) Neuartige polypeptide und ihre verwendung
DE60207878T2 (de) Lösungsmittelextraktionsverfahren
DE2705514B2 (de) Nonapeptide und diese enthaltende Arzneimittel
EP3346273B1 (de) Neue, von d3 abgeleitete d-enantiomere peptide und deren verwendung
DE69002881T2 (de) Peptide und deren Benutzung.
DE2540544C2 (de) (1-47)-Urogastron und das entsprechende durch Reduktion der Disulfidbindungen erhältliche Polypeptid, Verfahren zu deren Herstellung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen
DE2540545C2 (de) (1-46)-Urogastron und das entsprechende durch Reduktion der Disulfidbindungen erhältliche Polypeptid, Verfahren zu deren Herstellung und diese Polypeptide enthaltende pharmazeutische Zusammensetzungen
DE2732587C2 (enExample)
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
Gregory A new method for the preparation of urogastrone
DE2202613C3 (de) Verfahren zur Herstellung von Peptiden
DE69229202T2 (de) Verfahren zur reinigung von menschlichem bcdf
DE69626548T2 (de) Macrocyclische verbindungen die aus kohlensuboxi-gruppen besteht
DE60036638T2 (de) Verwendung von colostrinin, dessen peptidbestandteile und deren analoga zur förderung der neuronalen zelldifferenzierung

Legal Events

Date Code Title Description
OD Request for examination
D2 Grant after examination
8364 No opposition during term of opposition